Rebranded as Albion Capital
EM-focused companies looking appealing
Third anniversary this month
Launched in January
UK equity income continues to look relatively attractive in a world of low interest rates and low bond yields.
AstraZeneca is top holding at 7.4%
The casual observer of recent dividend trends in the UK may be forgiven for believing the income outlook has improved dramatically.